Practitioners prescribing semaglutide 0.15 mg, 0.25 mg per week - Microdoses -for conditions never studied, at doses never proven effective, based on a daisy chain of: Mouse studies that dont translate Dose-response curves that show threshold effects requiring higher doses Social media testimonials And wishful thinking From an insurance perspective, we cannot reimburse treatments without evidence of efficacy
Dark patches, and poor skin conditions are improved because of IV Glutathione Treatment
J Perinat Med 31 : 520522 Inanc F, Kilinc M, Kiran G, Guven A, Kurutas EB, Cikim IG, Akyol O 2005 Relationship between oxidative stress in cord blood and route of delivery
So even though research increasingly supports GLP-1 use in arthritis, autoimmune disease, fatty liver, kidney disease, and heart health, coverage outside of diabetes remains a constant battle
17,517 Pregabalin has linear pharmacokinetics, allowing for twice-daily dosing and a faster onset of action